Rashtriya Newsflash

Readers’ Favorite recognizes “Dolly’s Ocean Rescue” by Melissa Eastin in its annual international book award contest

Readers’ Favorite recognizes “Dolly’s Ocean Rescue” by Melissa Eastin in its annual international book award contest

Readers’ Favorite recognizes “Dolly’s Ocean Rescue” by Melissa Eastin in its annual international book award contest, currently available at http://www.amazon.com/gp/product/B0DMK3JR3F. The Readers’ Favorite International Book Award Contest featured thousands of

Read Full Article

Readers’ Favorite recognizes “Miri and The Honeybee” by NJ Lujan in its annual international book award contest

Readers’ Favorite recognizes “Miri and The Honeybee” by NJ Lujan in its annual international book award contest, currently available at http://www.amazon.com/gp/product/1965340660. The Readers’ Favorite International Book Award Contest featured thousands

Read Full Article

Readers’ Favorite recognizes “An American Tragedy” by Dan Flanigan in its annual international book award contest

Readers’ Favorite recognizes “An American Tragedy” by Dan Flanigan in its annual international book award contest, currently available at http://www.amazon.com/gp/product/B0CW1MVZHP. The Readers’ Favorite International Book Award Contest featured thousands of

Read Full Article

Presbyopia Pipeline Analysis & Clinical Trials Assessment, 2025, DelveInsight | Visus Therapeutics, Glaukos Corporation, Cellix Bio, Orasis Pharmaceuticals, Cellix Bio

Presbyopia Pipeline Analysis & Clinical Trials Assessment DelveInsight’s, “Presbyopia – Pipeline Insight, 2025” report provides comprehensive insights about 6+ companies and 6+ pipeline drugs in Presbyopia pipeline landscape. It covers

Read Full Article

Proliferative vitreoretinopathy Pipeline Analysis & Clinical Trials, 2025, DelveInsight | Aldeyra Therapeutics, Tetra Bio-Pharma, Aviceda Therapeutics

Proliferative vitreoretinopathy Pipeline DelveInsight’s, “Proliferative Vitreoretinopathy – Pipeline Insight, 2025,” report provides comprehensive insights about 3+ companies and 3+ pipeline

Read Full Article

Macular telangiectasia Pipeline Analysis & Clinical Trials Assessment, 2025, DelveInsight | OXURION, Neurotech Pharmaceuticals

Macular telangiectasia Pipeline DelveInsight’s, “Macular Telangiectasia (MacTel) Pipeline Insight, 2025,” report provides comprehensive insights about 4+ companies and 4+ pipeline

Read Full Article

Corneal ulcer Pipeline Analysis & Clinical Trials Assessment, 2025, DelveInsight | OcuNexus Therapeutics, Recordati Rare Diseases, Santen S.A.S., FirstString Research, Regeneratetx, Stuart Therapeutic

Corneal ulcer Pipeline Analysis & Clinical Trials Assessment DelveInsight’s, “Corneal Ulcer – Pipeline Insight, 2025,” report provides comprehensive insights about

Read Full Article

Vernal keratoconjunctivitis Pipeline Analysis & Clinical Trials, 2025, DelveInsight | iCo Therapeutics, Vanda Pharmaceuticals, Sylentis, Allakos

Vernal keratoconjunctivitis Pipeline DelveInsight’s, “Vernal Keratoconjunctivitis – Pipeline Insight, 2025,” report provides comprehensive insights about 5+ companies and 5+ pipeline

Read Full Article

Multiple System Atrophy Clinical Trials Analysis, 2025 | MSA Companies include Theravance Biopharma, H. Lundbeck A/S, Yoda Pharmaceuticals, Alterity Therapeutics, CORESTEM, Inc., ProMIS Neurosciences

Multiple System Atrophy Clinical Trials Analysis DelveInsight’s, “Multiple System Atrophy- Pipeline Insight, 2025” report provides comprehensive insights about 20+ companies

Read Full Article

Persistent corneal epithelial defects Pipeline Analysis, 2025 | PCEDs Clinical Trials | Eyevance, Amber Ophthalmics, Kala Pharmaceuticals, Noveome Biotherapeutics, Oyster Point Pharma

Persistent corneal epithelial defects Pipeline Analysis DelveInsight’s, “Persistent Corneal Epithelial Defects (PCEDs) – Pipeline Insight, 2025,” report provides comprehensive insights

Read Full Article